Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-6-28
|
pubmed:abstractText |
The synthesis of a series of 1,4-dihydropyridines which have N-linked heterocycles at the terminus of an ethoxymethyl chain at the 2-position is described. The calcium antagonist activity on rat aorta of this class of DHPs is compared with their negative inotropic activity as determined by using a Langendorff-perfused guinea pig heart model. The compounds examined show a wide range of selectivity for vascular over cardiac tissue, with those analogues which possess an amide group at the terminus of the 2-substituent proving the most selective. From the in vitro data obtained for a series of 1,2,3-triazoles, it is possible to conclude that the SARs for binding to the calcium channels in vascular and cardiac tissue are different. One of the compounds, 2-amino-1-[2-[[4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-5- (methoxycarbonyl)-6-methyl-1,4-dihydropyrid-2-yl]methoxy]ethyl]-4( 3H)- imidazolone (20b, UK-55,444), was identified as a potent (IC50 = 8 x 10(-9) M) calcium antagonist which is 40-fold selective for vascular over cardiac tissue and which has a significantly longer duration of action (greater than 3 h) than nifedipine in the anesthetized dog on intravenous administration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1805-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2342074-Animals,
pubmed-meshheading:2342074-Calcium Channel Blockers,
pubmed-meshheading:2342074-Dihydropyridines,
pubmed-meshheading:2342074-Dogs,
pubmed-meshheading:2342074-Guinea Pigs,
pubmed-meshheading:2342074-Imidazoles,
pubmed-meshheading:2342074-Muscle, Smooth, Vascular,
pubmed-meshheading:2342074-Myocardium,
pubmed-meshheading:2342074-Organ Specificity,
pubmed-meshheading:2342074-Rats,
pubmed-meshheading:2342074-Structure-Activity Relationship,
pubmed-meshheading:2342074-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonists.
|
pubmed:affiliation |
Pfizer Central Research, Sandwich, Kent, United Kingdom.
|
pubmed:publicationType |
Journal Article,
In Vitro
|